SCHEMBL2860913

SCHEMBL2860913

COC(=O)c1ccc2[nH]nc(-c3cccc(F)c3)c2c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 7/20 0.61
NTRK1 P04629 1/20 0.53
TTK P33981 2/20 0.47
MAPK8 P45983 2/20 0.47
MAPK1 P28482 4/20 0.46
MAP2K7 O14733 1/20 0.46
GABRA5 P31644 2/20 0.45
CSNK1D P48730 1/20 0.45
MAPK3 P27361 1/20 0.45
MAPKAPK3 Q16644 2/20 0.45
MAPK6 Q16659 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK14 Q16539 1/20 0.45
PARP1 P09874 1/20 0.44
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31632976 0.90 MAP2K4 (0.72) MAP2K4NTRK1TTKMAPK1MAP2K7
SCHEMBL31172414 0.87 MAP3K8 (0.54) MAP2K4NTRK1MEN1KMT2A
SCHEMBL2866811 0.85 MAP2K4 (0.55) MAP2K4TTKMAPK8MAPK1CSNK1D
SCHEMBL2858476 0.85 MAP2K4 (0.68) MAP2K4NTRK1TTKMAPK1MAPK3
SCHEMBL5801740 0.84 MAP2K4 (0.65) MAP2K4NTRK1TTKMAPK8MAPK1
Ethylene SCHEMBL27536148 0.82 MAP2K4 (0.65) MAP2K4NTRK1TTKMAPK1MAPK3
SCHEMBL27558524 0.82 MAP2K4 (0.54) MAP2K4NTRK1MAPK1MAP2K7CSNK1D
SCHEMBL2869817 0.81 MAP2K4 (0.54) MAP2K4NTRK1TTKMAPK1CSNK1D
SCHEMBL2868599 0.81 MAP2K4 (0.57) MAP2K4TTKMAPK8MAPK1CSNK1D
SCHEMBL2864413 0.81 MAP2K4 (0.60) MAP2K4NTRK1TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885NTRK1 1241/4885TTK 1201/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885NTRK1 1387/4885TTK 1066/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885NTRK1 1241/4885TTK 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.